N29I (p.Asn29Ile) variant of TP53 (Cellular tumor antigen p53)
N29I (p.Asn29Ile) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes experimental measurements and structural context.
N29I (p.Asn29Ile) variant details
- p.Asn29Ile
- Ensembl rs2073506642
- Uncertain significance
- Missense
- Variant Prioritization Score for Impact Estimate 0.261
- ESM-1b 0.00
- AlphaMissense 0.17
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available
- p53 variant effect measured by cell growth: score -0.641